ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

NCI Breast Cancer Overview Report Competed

August 5, 1988